AME vs KYMR · P/E 30, rev $2.04B vs rev $99.4M
Ametek Inc (AME) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
AME currently screens at market cap $42.11B and trailing P/E 29.9. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the AME and KYMR stock pages for the full models.
Not investment advice.